194 filings
Page 4 of 10
S-8
twgl1j
13 Sep 21
Registration of securities for employees
4:05pm
8-K
79lkbu
2 Sep 21
Chemomab Therapeutics Announces Appointment of Dale Pfost as Chief
7:11am
8-K
dhb6jbeqtx iywd99pg
13 Aug 21
Chemomab Therapeutics Announces Second Quarter 2021 Financial Results and Provides a
8:03am
8-K
lbll svnzdq8augwh
22 Jul 21
Submission of Matters to a Vote of Security Holders
8:30am
EFFECT
m3qiaiijbbw53g3z806
18 May 21
Notice of effectiveness
12:15am
8-K
u3x81u6ozc9wo j6sjw8
13 May 21
Chemomab Therapeutics Announces First Quarter 2021 Financial Results and Provides a Business Update
9:30am
CORRESP
7qubt
12 May 21
Correspondence with SEC
12:00am
UPLOAD
w3iht
5 May 21
Letter from SEC
12:00am
424B3
02n0azfx
29 Apr 21
Prospectus supplement
6:10am
EFFECT
wl18 efr3rw
29 Apr 21
Notice of effectiveness
12:15am
CORRESP
2ldl5qtky606h53507
26 Apr 21
Correspondence with SEC
12:00am
UPLOAD
8wrz7s
23 Apr 21
Letter from SEC
12:00am
S-3
btlrk187l44
15 Apr 21
Shelf registration
4:03pm